Increasing the purity, potency and specificity of ebv-specific T cells to improve the treatment of EBV-positive lymphoma

Ítems similars

• EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation
  per: McLaughlin, Lauren P., et al.
  Publicat: (2018)
• Manufacture of GMP-grade Cytotoxic T Lymphocytes specific for LMP1 and LMP2 for Patients with EBV-associated Lymphoma
  per: Bollard, Catherine M., et al.
  Publicat: (2011)
• Complementation of antigen presenting cells to generate T lymphocytes with broad target specificity
  per: Ngo, Minhtran C, et al.
  Publicat: (2014)
• Antitumor Activity of EBV-specific T Lymphocytes Transduced With a Dominant Negative TGF-β Receptor
  per: Foster, Aaron E., et al.
  Publicat: (2008)
• EBV Lymphoproliferative Disease after Hematopoietic Stem Cell Transplant
  per: Rouce, Rayne H, et al.
  Publicat: (2014)